<DOC>
	<DOCNO>NCT00375960</DOCNO>
	<brief_summary>The objective study investigate safety efficacy investigational drug , V3381 , treatment diabetic peripheral neuropathic ( DPN ) pain ( pain one 's foot leg , even one 's hand arm , sometimes experienced people diabetes ) . An investigational drug one approve United States Food Drug Administration ( FDA ) and/or Health Canada .</brief_summary>
	<brief_title>A Research Study V3381 Treatment Diabetic Peripheral Neuropathic Pain</brief_title>
	<detailed_description>Diabetic Peripheral Neuropathic Pain ( DPNP ) pain foot leg , even hand arm , sometimes experienced people diabetes . Neuropathic pain syndromes much common perhaps generally recognize . Approximately 1 % population western country suffers neuropathic pain . Some clinical condition associate relatively high incidence neuropathic pain . Approximately 15 % patient diabetic neuropathy persistent neuropathic pain foot , legs hand .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<criteria>Males female 1875 year age Diabetes mellitus ( type I type II ) No change medication reduce blood sugar within 4 week screen Experiencing daily pain due diabetic neuropathy least 6 month 5 year Neuropathic pain must begin foot , relatively symmetrical onset . Willing perform selfmonitoring blood glucose Able communicate intelligibly investigator study coordinator Keeping appointment clinic visit , test , procedures Any clinically significant neurologic disorder ( exception diabetic peripheral neuropathic pain ) Any clinically significant unstable medical psychiatric condition would interfere patient â€™ ability participate study Prior renal transplant current renal dialysis Pernicious anemia Untreated hypothyroidism Amputations due diabetes mellitus ( exception toe ) Any clinically significant abnormal electrocardiogram ( ECG ) Any history cardiac arrhythmia History myocardial infarction Active angina Uncontrolled hypertension ( i.e. , &gt; 140/90 mm Hg ) Known high risk hepatitis B C infection Known high risk human immunodeficiency virus ( HIV ) infection Any anticipate need surgery study Glycosylated hemoglobin ( HbA1c ) &gt; 9 % Known seizure disorder Any malignancy past 2 year ( exception basal cell carcinoma ) Pain clearly differentiate , condition interfere assessment diabetic neuropathic pain . Use anticonvulsant , antidepressant , prescription membranestabilizing agent History substance abuse dependence within past year , exclude nicotine caffeine Frequent and/or severe allergic reaction multiple medication Participation clinical trial within 30 day screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Pain associate diabetes Type I Type II</keyword>
	<keyword>Neuropathic Pain due diabetes</keyword>
	<keyword>Diabetic peripheral neuropathic pain</keyword>
	<keyword>Pain</keyword>
	<keyword>Diabetes burn sensation arm and/or leg</keyword>
	<keyword>Diabetes tingle sensation arm and/or leg</keyword>
	<keyword>Neuropathic Pain Due Diabetes Type I Type II</keyword>
</DOC>